Glaxo, Inc.
This article was originally published in The Tan Sheet
Executive Summary
President Robert Ingrain adds title of CEO. Charles Sanders, MD, will remain chairman of Glaxo's U.S. subsidiary. Ingram, 51, joined Glaxo from Merck in 1990. He was Merck's Washington, D.C. representative in the mid-1980s